GBL acquiring co-controlling stake in Rayner for €500m
Belgian-based, publicly traded investment holding company Groupe Bruxelles Lambert (GBL) has signed definitive agreements to acquire a 45% co-control stake in UK-based manufacturer of intraocular lenses and ophthalmic medical products Rayner. The transaction involves an equity investment of approximately €500m and will see GBL partnering with incumbent shareholder CVC Capital Partners and Rayner’s management team. Completion of the deal is…
EssilorLuxottica buys Signifeye and announces research tie-up
Global eyewear giant EssilorLuxottica has reached agreement to acquire Signifeye, a privately held ophthalmology platform running 15 eye centres and clinics across the Flanders region of Belgium. Announced on Friday, December 12, the deal lands just months after the group’s purchase of Optegra, a 70-site network spanning five European countries, and signals continued momentum in building a pan-European clinical footprint. Management…
EssilorLuxottica unveils challenge to invasive myopia treatment
EssilorLuxottica’s unveiling of Stellest 2.0 spectacle lenses at China’s International Import Expo on November 5 points to a data-driven, non-invasive alternative to atropine drops or refractive surgery, potentially redirecting paediatric eye-care pathways. Med-tech players should note the lens-plus-sensor model, which marries diagnostics, compliance analytics, and hardware – is an architecture transferrable to other chronic-care settings. EssilorLuxottica is a global leader in…
Alcon broadens Vision Care Portfolio with $1.5bn Acquisition of STAAR Surgical
Swiss-American pharmaceutical and medical device company Alcon has struck a definitive agreement to purchase STAAR Surgical in a deal which values the phakic IOL specialist at roughly $1.5 billion, but the shareholder vote on the takeover offer has been delayed until November 6.
Post-closing implications as EssilorLuxottica closes Optegra acquisition
EssilorLuxottica has closed the purchase of Optegra, a 70-clinic ophthalmology network spanning the UK, Czech Republic, Poland, Slovakia and the Netherlands. The transaction vaults the group from a dominant eyewear manufacturer-retailer into a vertically integrated eye-health services platform capable of owning the entire patient journey—from screening and diagnosis to surgery, prescription, and connected eyewear. How will this reshape the global…